首页 > 最新文献

Journal of cancer & allied specialties最新文献

英文 中文
A Rare Case of Primary Malignant Melanoma of Cervical Spine Having Extramedullary Intradural Origin: A Single Case Report and Literature Review. 一例罕见的颈椎髓外髓内原发性恶性黑色素瘤:一例病例报告和文献综述。
Pub Date : 2024-01-22 eCollection Date: 2024-01-01 DOI: 10.37029/jcas.v10i1.513
Irfan Haider, Sarah Khan, Fawad Ul Qamar, Yasir Inam, Kashmala Gul, Iftikhar Ali Rana

Introduction: Primary spinal malignant melanoma (PSMM) of extramedullary intradural origin is a rare malignant condition with limited current literature regarding its clinical course, magnetic resonance imaging (MRI) findings, treatment strategies, and outcomes.

Case discussion: This is a case report of a patient with PSMM who was treated with surgery followed by radiotherapy for his residual disease in Shaukat Khanum Memorial Trust, Pakistan. The clinical and radiological findings of this case were retrospectively analyzed using the Hospital Information System.

Practical implementations: PSMM of extramedullary intradural origin is a rare malignant tumor that shows characteristic findings on MRI. Surgical resection is the preferred treatment, and radiotherapy is useful for residual disease.

简介:髓外硬膜内原发性脊柱恶性黑色素瘤(Primary spinal malignant melanoma,PSMM)是一种罕见的恶性肿瘤,目前有关其临床过程、磁共振成像(MRI)结果、治疗策略和疗效的文献有限:这是巴基斯坦肖卡特-卡努姆纪念信托基金会(Shaukat Khanum Memorial Trust)的一例 PSMM 患者的病例报告。我们利用医院信息系统对该病例的临床和放射学检查结果进行了回顾性分析:髓外硬膜内 PSMM 是一种罕见的恶性肿瘤,在核磁共振成像上显示出特征性结果。手术切除是首选治疗方法,放射治疗对残留病灶有帮助。
{"title":"A Rare Case of Primary Malignant Melanoma of Cervical Spine Having Extramedullary Intradural Origin: A Single Case Report and Literature Review.","authors":"Irfan Haider, Sarah Khan, Fawad Ul Qamar, Yasir Inam, Kashmala Gul, Iftikhar Ali Rana","doi":"10.37029/jcas.v10i1.513","DOIUrl":"10.37029/jcas.v10i1.513","url":null,"abstract":"<p><strong>Introduction: </strong>Primary spinal malignant melanoma (PSMM) of extramedullary intradural origin is a rare malignant condition with limited current literature regarding its clinical course, magnetic resonance imaging (MRI) findings, treatment strategies, and outcomes.</p><p><strong>Case discussion: </strong>This is a case report of a patient with PSMM who was treated with surgery followed by radiotherapy for his residual disease in Shaukat Khanum Memorial Trust, Pakistan. The clinical and radiological findings of this case were retrospectively analyzed using the Hospital Information System.</p><p><strong>Practical implementations: </strong>PSMM of extramedullary intradural origin is a rare malignant tumor that shows characteristic findings on MRI. Surgical resection is the preferred treatment, and radiotherapy is useful for residual disease.</p>","PeriodicalId":73631,"journal":{"name":"Journal of cancer & allied specialties","volume":"10 1","pages":"513"},"PeriodicalIF":0.0,"publicationDate":"2024-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10793715/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139522402","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Complications and Outcome of Bone Sarcoma Patients with Limb Salvage using Liquid Nitrogen-treated Bone for Reconstruction. 使用液氮处理过的骨骼进行肢体重建的骨肉瘤患者的并发症和结果
Pub Date : 2024-01-22 eCollection Date: 2024-01-01 DOI: 10.37029/jcas.v10i1.543
Muhammad Zoha Farooq, Muhammad Bilal Shafiq, Sajid Ali, Ilyas Rafi

Introduction: The recommended treatment method for bone sarcoma is wide local excision and reconstruction to preserve limb function. Established methods of reconstruction are mega prosthesis or biological reconstruction. This study aimed to determine the complications and functional outcomes associated with limb salvage surgery using liquid nitrogen-treated bone.

Materials and methods: We retrospectively observed the short-term outcome of limb salvage surgeries where liquid nitrogen bone was used for reconstruction. A total of 15 patients underwent reconstruction with liquid nitrogen auto graft from January 2018 to December 2020. We used the free freezing method of liquid nitrogen treatment after wide local excision of sarcoma. We observed short-term outcomes after liquid nitrogen-treated bone reconstruction in limb salvage surgery. Survival of the auto grafts was recorded using the Kaplan-Meier method with a 95% confidence interval.

Results: The mean follow-up was 19.83 ± 4.5 months. The mean musculoskeletal tumor society score was 62.4 ± 7.9%, while the average Toronto extremity score was 59.6 ± 5.7%. Three patients died during the study duration due to visceral metastasis. Skin necrosis and wound breakdown were major complications in 9 (60%) patients. Deep infection was observed in 4 (26.7%). Similarly, 4 (26.7%) patients had non-union at either the proximal or distal osteotomy site, while the average time of bone union in the rest of the patients was 6.3 ± 1.7 months. A total of 6 (40%) patients underwent reoperation after liquid nitrogen treatment, either due to infection or non-union at the osteotomy site. Recurrence was observed in 3 (20%) of patients.

Conclusion: We observed a high complication rate with liquid nitrogen-treated autograft reconstruction. Vascularized fibula with liquid nitrogen-treated autograft or endoprosthesis should be encouraged.

导言骨肉瘤的推荐治疗方法是局部广泛切除和重建,以保留肢体功能。现有的重建方法是巨型假肢或生物重建。本研究旨在确定使用液氮处理骨进行肢体救治手术的相关并发症和功能结果:我们回顾性地观察了使用液氮骨进行重建的肢体挽救手术的短期疗效。自2018年1月至2020年12月,共有15名患者接受了液氮自体移植重建手术。我们在肉瘤广泛局部切除术后采用了液氮冷冻治疗方法。我们观察了肢体救治手术中液氮处理骨重建后的短期疗效。采用Kaplan-Meier法记录自体移植物的存活率,置信区间为95%:平均随访时间为(19.83 ± 4.5)个月。肌肉骨骼肿瘤协会平均评分为 62.4 ± 7.9%,多伦多肢体平均评分为 59.6 ± 5.7%。三名患者在研究期间因内脏转移而死亡。皮肤坏死和伤口破裂是 9 例(60%)患者的主要并发症。4例(26.7%)患者出现深度感染。同样,4 例(26.7%)患者的近端或远端截骨部位出现骨不连,其余患者的平均骨不连时间为 6.3 ± 1.7 个月。共有 6 名(40%)患者在液氮治疗后因感染或截骨部位未愈合而接受了再次手术。3例(20%)患者出现复发:我们观察到液氮处理的自体移植物重建术并发症发生率很高。应鼓励使用液氮处理的自体移植物或内假体进行血管化腓骨重建。
{"title":"Complications and Outcome of Bone Sarcoma Patients with Limb Salvage using Liquid Nitrogen-treated Bone for Reconstruction.","authors":"Muhammad Zoha Farooq, Muhammad Bilal Shafiq, Sajid Ali, Ilyas Rafi","doi":"10.37029/jcas.v10i1.543","DOIUrl":"10.37029/jcas.v10i1.543","url":null,"abstract":"<p><strong>Introduction: </strong>The recommended treatment method for bone sarcoma is wide local excision and reconstruction to preserve limb function. Established methods of reconstruction are mega prosthesis or biological reconstruction. This study aimed to determine the complications and functional outcomes associated with limb salvage surgery using liquid nitrogen-treated bone.</p><p><strong>Materials and methods: </strong>We retrospectively observed the short-term outcome of limb salvage surgeries where liquid nitrogen bone was used for reconstruction. A total of 15 patients underwent reconstruction with liquid nitrogen auto graft from January 2018 to December 2020. We used the free freezing method of liquid nitrogen treatment after wide local excision of sarcoma. We observed short-term outcomes after liquid nitrogen-treated bone reconstruction in limb salvage surgery. Survival of the auto grafts was recorded using the Kaplan-Meier method with a 95% confidence interval.</p><p><strong>Results: </strong>The mean follow-up was 19.83 ± 4.5 months. The mean musculoskeletal tumor society score was 62.4 ± 7.9%, while the average Toronto extremity score was 59.6 ± 5.7%. Three patients died during the study duration due to visceral metastasis. Skin necrosis and wound breakdown were major complications in 9 (60%) patients. Deep infection was observed in 4 (26.7%). Similarly, 4 (26.7%) patients had non-union at either the proximal or distal osteotomy site, while the average time of bone union in the rest of the patients was 6.3 ± 1.7 months. A total of 6 (40%) patients underwent reoperation after liquid nitrogen treatment, either due to infection or non-union at the osteotomy site. Recurrence was observed in 3 (20%) of patients.</p><p><strong>Conclusion: </strong>We observed a high complication rate with liquid nitrogen-treated autograft reconstruction. Vascularized fibula with liquid nitrogen-treated autograft or endoprosthesis should be encouraged.</p>","PeriodicalId":73631,"journal":{"name":"Journal of cancer & allied specialties","volume":"10 1","pages":"543"},"PeriodicalIF":0.0,"publicationDate":"2024-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10793719/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139522406","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Longitudinal Metagenomic Comparative Analysis of Oral Microbiome Shifts in Patients Receiving Proton Radiation versus Photon Radiation for Head and Neck Cancer. 对接受质子辐射与光子辐射治疗头颈癌患者口腔微生物组变化的纵向元基因组对比分析
Pub Date : 2024-01-22 eCollection Date: 2024-01-01 DOI: 10.37029/jcas.v10i1.579
Timothy F Meiller, Claire M Fraser, Silvia Grant-Beurmann, Mike Humphrys, Luke Tallon, Lisa D Sadzewicz, Mary Ann Jabra-Rizk, Areej Alfaifi, Anmar Kensara, Jason K Molitoris, Matthew Witek, William S Mendes, William F Regine, Phuoc T Tran, Robert C Miller, Ahmed S Sultan

Introduction: Due to the radiation-sparing effects on salivary gland acini, changes in the composition of the oral microbiome may be a driver for improved outcomes in patients receiving proton radiation, with potentially worse outcomes in patients exposed to photon radiation therapy. To date, a head-to-head comparison of oral microbiome changes at a metagenomic level with longitudinal sampling has yet to be performed in these patient cohorts.

Methods and materials: To comparatively analyze oral microbiome shifts during head and neck radiation therapy, a prospective pilot cohort study was performed at the Maryland Proton Treatment Center and the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center. A longitudinal metagenomic comparative analysis of oral microbiome shifts was performed at three time points (pre-radiation, during radiation, and immediately post-radiation). Head and neck cancer patients receiving proton radiation (n = 4) were compared to photon radiation (n = 4). Additional control groups included healthy age- and sex-matched controls (n = 5), head and neck cancer patients who never received radiation therapy (n = 8), and patients with oral inflammatory disease (n = 3).

Results: Photon therapy patients presented with lower microbial alpha diversity at all timepoints, and there was a trend towards reduced species richness as compared with proton therapy. Healthy controls and proton patients exhibited overall higher and similar diversity. A more dysbiotic state was observed in patients receiving photon therapy as compared to proton therapy, in which oral microbial homeostasis was maintained. Mucositis was observed in 3/4 photon patients and was not observed in any proton patients during radiation therapy. The bacterial de novo pyrimidine biosynthesis pathway and the nitrate reduction V pathway were comparatively higher following photon exposure. These functional changes in bacterial metabolism may suggest that photon exposure produces a more permissive environment for the proliferation of pathogenic bacteria.

Conclusion: Oral microbiome dysbiosis in patients receiving photon radiation may be associated with increased mucositis occurrence. Proton radiation therapy for head and neck cancer demonstrates a safer side effect profile in terms of oral complications, oral microbiome dysbiosis, and functional metabolic status.

简介由于放射线对唾液腺尖锐湿疣有保护作用,口腔微生物组组成的变化可能是改善质子放射治疗患者预后的驱动因素,而光子放射治疗患者的预后可能较差。迄今为止,在这些患者队列中,还没有在元基因组水平上对口腔微生物组的变化进行头对头的比较和纵向采样:为了比较分析头颈部放射治疗期间口腔微生物组的变化,马里兰质子治疗中心和马里兰大学马琳和斯图尔特-格林鲍姆综合癌症中心开展了一项前瞻性试点队列研究。在三个时间点(放射前、放射期间和放射后)对口腔微生物组的变化进行了纵向元基因组比较分析。接受质子辐射(4 人)的头颈部癌症患者与接受光子辐射(4 人)的头颈部癌症患者进行了比较。其他对照组包括年龄和性别匹配的健康对照组(5 人)、从未接受过放射治疗的头颈部癌症患者(8 人)和口腔炎症患者(3 人):光子治疗患者在所有时间点的微生物α多样性都较低,与质子治疗相比,物种丰富度呈下降趋势。健康对照组和质子治疗患者的微生物多样性总体较高且相似。与质子疗法相比,接受光子疗法的患者口腔微生物平衡保持良好,而接受质子疗法的患者则更容易出现菌群失调。在放疗期间,3/4 的光子患者出现了口腔粘膜炎,而质子患者没有出现口腔粘膜炎。光子照射后,细菌的新嘧啶生物合成途径和硝酸盐还原 V 途径相对较高。细菌新陈代谢的这些功能变化可能表明,光子照射为致病菌的增殖创造了更有利的环境:结论:接受光子照射的患者口腔微生物群失调可能与粘膜炎发生率增加有关。就口腔并发症、口腔微生物群失调和功能代谢状况而言,头颈部癌症质子放射治疗的副作用更安全。
{"title":"A Longitudinal Metagenomic Comparative Analysis of Oral Microbiome Shifts in Patients Receiving Proton Radiation versus Photon Radiation for Head and Neck Cancer.","authors":"Timothy F Meiller, Claire M Fraser, Silvia Grant-Beurmann, Mike Humphrys, Luke Tallon, Lisa D Sadzewicz, Mary Ann Jabra-Rizk, Areej Alfaifi, Anmar Kensara, Jason K Molitoris, Matthew Witek, William S Mendes, William F Regine, Phuoc T Tran, Robert C Miller, Ahmed S Sultan","doi":"10.37029/jcas.v10i1.579","DOIUrl":"10.37029/jcas.v10i1.579","url":null,"abstract":"<p><strong>Introduction: </strong>Due to the radiation-sparing effects on salivary gland acini, changes in the composition of the oral microbiome may be a driver for improved outcomes in patients receiving proton radiation, with potentially worse outcomes in patients exposed to photon radiation therapy. To date, a head-to-head comparison of oral microbiome changes at a metagenomic level with longitudinal sampling has yet to be performed in these patient cohorts.</p><p><strong>Methods and materials: </strong>To comparatively analyze oral microbiome shifts during head and neck radiation therapy, a prospective pilot cohort study was performed at the Maryland Proton Treatment Center and the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center. A longitudinal metagenomic comparative analysis of oral microbiome shifts was performed at three time points (pre-radiation, during radiation, and immediately post-radiation). Head and neck cancer patients receiving proton radiation (<i>n</i> = 4) were compared to photon radiation (<i>n</i> = 4). Additional control groups included healthy age- and sex-matched controls (<i>n</i> = 5), head and neck cancer patients who never received radiation therapy (<i>n</i> = 8), and patients with oral inflammatory disease (<i>n</i> = 3).</p><p><strong>Results: </strong>Photon therapy patients presented with lower microbial alpha diversity at all timepoints, and there was a trend towards reduced species richness as compared with proton therapy. Healthy controls and proton patients exhibited overall higher and similar diversity. A more dysbiotic state was observed in patients receiving photon therapy as compared to proton therapy, in which oral microbial homeostasis was maintained. Mucositis was observed in 3/4 photon patients and was not observed in any proton patients during radiation therapy. The bacterial de novo pyrimidine biosynthesis pathway and the nitrate reduction V pathway were comparatively higher following photon exposure. These functional changes in bacterial metabolism may suggest that photon exposure produces a more permissive environment for the proliferation of pathogenic bacteria.</p><p><strong>Conclusion: </strong>Oral microbiome dysbiosis in patients receiving photon radiation may be associated with increased mucositis occurrence. Proton radiation therapy for head and neck cancer demonstrates a safer side effect profile in terms of oral complications, oral microbiome dysbiosis, and functional metabolic status.</p>","PeriodicalId":73631,"journal":{"name":"Journal of cancer & allied specialties","volume":"10 1","pages":"579"},"PeriodicalIF":0.0,"publicationDate":"2024-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10793722/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139522393","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association of Wilms Tumor with Crossed Fused Renal Ectopia in Children: A Case Report. 儿童 Wilms 肿瘤与交叉融合性肾外翻的关联:病例报告
Pub Date : 2024-01-22 eCollection Date: 2024-01-01 DOI: 10.37029/jcas.v10i1.601
Sajid Ali, Tariq Latif, Muhammad Ali Sheikh, Muhammad Bilal Shafiq

Introduction: Wilms tumor is the most common renal malignancy in children. The occurrence of Wilms tumor with various congenital genitourinary anomalies has been reported, particularly in horseshoe kidneys, hypospadias, disorder of sexual development, and double collecting system. However, Wilms tumor with crossed renal ectopia is a rare finding.

Case description: We are reporting a case report of Wilms tumor in a 3-year-old girl who presented with a huge left flank mass with cross-fused renal ectopia. After the initial workup and triphasic computed tomography scan of the chest, abdomen, and pelvis for confirmation of diagnosis and metastasis, the patient underwent image-guided tissue biopsy, followed by neoadjuvant chemotherapy, left radical nephrectomy with separation of fused right ectopic renal moiety, and adjuvant chemoradiation.

Practical implication: This report shows an association of Wilms tumor with cross-fused renal ectopia, a rare combination. Unusual findings on imaging with unilateral flank mass should be considered as part of the differential diagnosis for this rare finding. Adjuvant chemotherapy and modern imaging helped delineate the anatomy and ease the surgery for safe resection, improving the overall outcome.

导言Wilms 肿瘤是儿童最常见的肾脏恶性肿瘤。Wilms瘤合并各种先天性泌尿生殖系统畸形的情况时有报道,尤其是马蹄肾、尿道下裂、性发育障碍和双集合系统。然而,Wilms瘤合并交叉性肾异位却是罕见病例:我们报告了一例 Wilms 肿瘤病例,患者是一名 3 岁女童,左侧腹部巨大肿块,伴有交叉融合的肾外翻。经过初步检查和胸部、腹部和盆腔三相计算机断层扫描确诊和转移后,患者接受了图像引导下的组织活检,随后接受了新辅助化疗、左侧根治性肾切除术(分离融合的右侧异位肾)和辅助化疗:本报告显示了 Wilms 肿瘤与交叉融合性肾异位的关联,这是一种罕见的合并症。对于这一罕见病例的鉴别诊断,应考虑单侧侧腹肿块的影像学异常发现。辅助化疗和现代影像学检查有助于确定解剖结构,为手术安全切除提供了便利,从而改善了总体预后。
{"title":"Association of Wilms Tumor with Crossed Fused Renal Ectopia in Children: A Case Report.","authors":"Sajid Ali, Tariq Latif, Muhammad Ali Sheikh, Muhammad Bilal Shafiq","doi":"10.37029/jcas.v10i1.601","DOIUrl":"10.37029/jcas.v10i1.601","url":null,"abstract":"<p><strong>Introduction: </strong>Wilms tumor is the most common renal malignancy in children. The occurrence of Wilms tumor with various congenital genitourinary anomalies has been reported, particularly in horseshoe kidneys, hypospadias, disorder of sexual development, and double collecting system. However, Wilms tumor with crossed renal ectopia is a rare finding.</p><p><strong>Case description: </strong>We are reporting a case report of Wilms tumor in a 3-year-old girl who presented with a huge left flank mass with cross-fused renal ectopia. After the initial workup and triphasic computed tomography scan of the chest, abdomen, and pelvis for confirmation of diagnosis and metastasis, the patient underwent image-guided tissue biopsy, followed by neoadjuvant chemotherapy, left radical nephrectomy with separation of fused right ectopic renal moiety, and adjuvant chemoradiation.</p><p><strong>Practical implication: </strong>This report shows an association of Wilms tumor with cross-fused renal ectopia, a rare combination. Unusual findings on imaging with unilateral flank mass should be considered as part of the differential diagnosis for this rare finding. Adjuvant chemotherapy and modern imaging helped delineate the anatomy and ease the surgery for safe resection, improving the overall outcome.</p>","PeriodicalId":73631,"journal":{"name":"Journal of cancer & allied specialties","volume":"10 1","pages":"601"},"PeriodicalIF":0.0,"publicationDate":"2024-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10793717/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139522404","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reduction in Average Length-of-Stay in Emergency Department of a Low-Income Country's Cancer Hospital. 减少低收入国家癌症医院急诊科的平均住院时间。
Pub Date : 2024-01-22 eCollection Date: 2024-01-01 DOI: 10.37029/jcas.v10i1.537
Qurratulain Shakoor, Haroon Hafeez, Atif Saleem, Zubair Shabbir Khanzada, Hira Safir, Zainab Ajmal, Kashif Sajjad

Introduction: Prolonged length of stay (LOS) in emergency departments (ED) is a widespread problem in every hospital around the globe. Multiple factors cause it and can have a negative impact on the quality of care provided to the patients and the patient satisfaction rates. This project aimed to ensure that the average LOS of patients in a tertiary care cancer hospital stays below 3 hours.

Materials and methods: The Six Sigma DMAIC (Define, Measure, Analyze, Improve, Control) approach was followed.

Results: The average LOS was 166 minutes before implementing interventions. The two primary reasons for the increased length of stay were delays secondary to physician assessment and diagnostic lab reports. Strategies were defined to control these factors, which helped reduce the average length of stay to 142 minutes, a 30% reduction.

Conclusion: A process improvement model similar to this project is recommended to enhance the quality of hospital services. It will provide valuable insights into the process flow and assist in gathering precise data on the various steps involved. The data collected can then be analyzed to identify potential causes and make informed decisions that can significantly improve hospital processes.

导言:急诊科(ED)的住院时间(LOS)过长是全球每家医院都普遍存在的问题。造成这一问题的原因是多方面的,而且会对为患者提供的医疗服务质量和患者满意度产生负面影响。本项目旨在确保一家三级癌症医院患者的平均候诊时间保持在 3 小时以下:采用六西格玛 DMAIC(定义、测量、分析、改进、控制)方法:结果:在实施干预措施之前,平均住院时间为 166 分钟。住院时间延长的两个主要原因是医生评估和实验室诊断报告造成的延误。我们制定了控制这些因素的策略,从而将平均住院时间缩短至 142 分钟,缩短了 30%:建议采用与本项目类似的流程改进模式来提高医院服务质量。它将为流程提供有价值的见解,并有助于收集有关各个步骤的精确数据。然后可以对收集到的数据进行分析,找出潜在的原因,并做出明智的决定,从而大大改善医院的流程。
{"title":"Reduction in Average Length-of-Stay in Emergency Department of a Low-Income Country's Cancer Hospital.","authors":"Qurratulain Shakoor, Haroon Hafeez, Atif Saleem, Zubair Shabbir Khanzada, Hira Safir, Zainab Ajmal, Kashif Sajjad","doi":"10.37029/jcas.v10i1.537","DOIUrl":"10.37029/jcas.v10i1.537","url":null,"abstract":"<p><strong>Introduction: </strong>Prolonged length of stay (LOS) in emergency departments (ED) is a widespread problem in every hospital around the globe. Multiple factors cause it and can have a negative impact on the quality of care provided to the patients and the patient satisfaction rates. This project aimed to ensure that the average LOS of patients in a tertiary care cancer hospital stays below 3 hours.</p><p><strong>Materials and methods: </strong>The Six Sigma DMAIC (Define, Measure, Analyze, Improve, Control) approach was followed.</p><p><strong>Results: </strong>The average LOS was 166 minutes before implementing interventions. The two primary reasons for the increased length of stay were delays secondary to physician assessment and diagnostic lab reports. Strategies were defined to control these factors, which helped reduce the average length of stay to 142 minutes, a 30% reduction.</p><p><strong>Conclusion: </strong>A process improvement model similar to this project is recommended to enhance the quality of hospital services. It will provide valuable insights into the process flow and assist in gathering precise data on the various steps involved. The data collected can then be analyzed to identify potential causes and make informed decisions that can significantly improve hospital processes.</p>","PeriodicalId":73631,"journal":{"name":"Journal of cancer & allied specialties","volume":"10 1","pages":"537"},"PeriodicalIF":0.0,"publicationDate":"2024-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10793720/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139520119","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Survival Analysis and Correlates with Molecular Epidemiology: 10-Year Retrospective Series of High-Grade Glioma in Pakistan. 生存期分析及与分子流行病学的相关性:巴基斯坦高级别胶质瘤 10 年回顾性系列研究。
Pub Date : 2024-01-22 eCollection Date: 2024-01-01 DOI: 10.37029/jcas.v10i1.565
Mashal Shah, Saad Bin Anis, Irfan Yusuf, Mohammad Hamza Bajwa

Introduction: High-grade gliomas are malignant, recurring primary central nervous system (CNS) tumors requiring extensive postoperative chemotherapy and radiation treatment. Isocitrate dehydrogenase (IDH), 1p19q, and ATRX mutations significantly influence survival and response to chemotherapy, as seen in many extensive studies from the Global North. This study aims to report data from the local region regarding progression-free survival and overall survival in light of molecular characteristics.

Materials and methods: A 10-year retrospective series was conducted at the Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan, with 285 patients presenting from 2008 to 2018. Prospective follow-up data was collected, and complete molecular profiles were available for patients presenting from 2010 onwards. Survival analysis was conducted through the Kaplan-Meier method, with log-rank reported.

Results: 70.53% (201) of patients were male, with a mean age at diagnosis of 43.33 ± 15.1 years. 265 patients within the cohort completed postoperative radiotherapy, while 141 patients underwent chemotherapy (procarbazine, lomustine, and vincristine, or temozolomide). Mean survival, in months, within the cohort was as follows: glioblastoma (14.1), anaplastic astrocytoma (27.5), and anaplastic oligodendroglioma (39.8). Survival curves showed a lower survival for IDH wild-type (P < 0.0001), ATRX mutated (P = 0.029), and 1p19q non-deleted (P = 0.008) tumors from Pakistan.

Discussion: Our findings quantified long-term survival outcomes for high-grade glioma from Pakistan, analyzing the various treatment patterns. Of particular importance, molecular sub-classification significantly predicted survival outcomes for IDH, ATRX, and 1p19 co-deletion mutations. Expanding brain tumor epidemiology will benefit assessing the efficacy of regional oncological centers and establishing standards of care.

简介高级别胶质瘤是一种恶性、复发性原发性中枢神经系统(CNS)肿瘤,需要大量的术后化疗和放疗。异柠檬酸脱氢酶(IDH)、1p19q 和 ATRX 基因突变对患者的生存和化疗反应有显著影响,这一点在全球北方地区的许多广泛研究中都有体现。本研究旨在根据分子特征报告当地地区的无进展生存期和总生存期数据:巴基斯坦拉合尔的肖卡特-卡努姆纪念癌症医院和研究中心开展了一项为期 10 年的回顾性系列研究,共有 285 名患者在 2008 年至 2018 年期间就诊。收集了前瞻性随访数据,并为2010年以后的患者提供了完整的分子图谱。通过卡普兰-梅耶法进行生存分析,并报告对数秩:70.53%的患者(201人)为男性,诊断时的平均年龄为(43.33 ± 15.1)岁。队列中有 265 名患者完成了术后放疗,141 名患者接受了化疗(丙卡巴嗪、洛莫司汀和长春新碱或替莫唑胺)。队列中以月为单位的平均生存期如下:胶质母细胞瘤(14.1 个月)、无细胞星形细胞瘤(27.5 个月)和无细胞少突胶质细胞瘤(39.8 个月)。生存曲线显示,来自巴基斯坦的IDH野生型肿瘤(P < 0.0001)、ATRX突变肿瘤(P = 0.029)和1p19q未缺失肿瘤(P = 0.008)的生存率较低:我们的研究结果量化了巴基斯坦高级别胶质瘤患者的长期生存结果,分析了各种治疗模式。尤其重要的是,分子亚分类可显著预测IDH、ATRX和1p19共缺失突变的生存结果。扩大脑肿瘤流行病学将有利于评估地区肿瘤中心的疗效和建立治疗标准。
{"title":"Survival Analysis and Correlates with Molecular Epidemiology: 10-Year Retrospective Series of High-Grade Glioma in Pakistan.","authors":"Mashal Shah, Saad Bin Anis, Irfan Yusuf, Mohammad Hamza Bajwa","doi":"10.37029/jcas.v10i1.565","DOIUrl":"10.37029/jcas.v10i1.565","url":null,"abstract":"<p><strong>Introduction: </strong>High-grade gliomas are malignant, recurring primary central nervous system (CNS) tumors requiring extensive postoperative chemotherapy and radiation treatment. Isocitrate dehydrogenase (IDH), 1p19q, and ATRX mutations significantly influence survival and response to chemotherapy, as seen in many extensive studies from the Global North. This study aims to report data from the local region regarding progression-free survival and overall survival in light of molecular characteristics.</p><p><strong>Materials and methods: </strong>A 10-year retrospective series was conducted at the Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan, with 285 patients presenting from 2008 to 2018. Prospective follow-up data was collected, and complete molecular profiles were available for patients presenting from 2010 onwards. Survival analysis was conducted through the Kaplan-Meier method, with log-rank reported.</p><p><strong>Results: </strong>70.53% (201) of patients were male, with a mean age at diagnosis of 43.33 ± 15.1 years. 265 patients within the cohort completed postoperative radiotherapy, while 141 patients underwent chemotherapy (procarbazine, lomustine, and vincristine, or temozolomide). Mean survival, in months, within the cohort was as follows: glioblastoma (14.1), anaplastic astrocytoma (27.5), and anaplastic oligodendroglioma (39.8). Survival curves showed a lower survival for IDH wild-type (<i>P</i> < 0.0001), ATRX mutated (<i>P</i> = 0.029), and 1p19q non-deleted (<i>P</i> = 0.008) tumors from Pakistan.</p><p><strong>Discussion: </strong>Our findings quantified long-term survival outcomes for high-grade glioma from Pakistan, analyzing the various treatment patterns. Of particular importance, molecular sub-classification significantly predicted survival outcomes for IDH, ATRX, and 1p19 co-deletion mutations. Expanding brain tumor epidemiology will benefit assessing the efficacy of regional oncological centers and establishing standards of care.</p>","PeriodicalId":73631,"journal":{"name":"Journal of cancer & allied specialties","volume":"10 1","pages":"565"},"PeriodicalIF":0.0,"publicationDate":"2024-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10793716/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139520250","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pediatric Ewing Sarcoma of Kidney: A Case Series and Review of Literature. 小儿肾脏尤文肉瘤:病例系列和文献综述
Pub Date : 2024-01-22 eCollection Date: 2024-01-01 DOI: 10.37029/jcas.v10i1.563
Areej Salim, Sajid Ali, Tariq Latif

Introduction: Renal Ewing sarcoma is an aggressive and rare malignancy affecting children and adolescents. Limited data on its management contribute to uncertainties in treatment.

Case description: We present two pediatric cases of renal Ewing sarcoma. Both cases emphasize the significance of accurate diagnosis, multimodal treatment, and long-term follow-up in achieving favorable outcomes. Accurate diagnosis of renal Ewing sarcoma is crucial for effective management. Multimodal treatment involving neoadjuvant chemotherapy, surgical resection and staging with lymph node sampling, and chemotherapy continuation has shown promising results in our cases. Long-term follow-up is essential for monitoring disease progression and ensuring optimal outcomes.

Practical implications: There is limited data published about these renal tumors, especially in the pediatric population, and most studies lack long-term follow-up, with uncertain management due to limited data. This data will add to the newer, multimodal approach and form the basis for future meta-analysis to help formulate guidelines for upcoming international meetings. Continued research efforts are necessary to optimize strategies and improve the prognosis for pediatric patients with renal Ewing sarcoma.

简介肾尤文肉瘤是一种侵袭性的罕见恶性肿瘤,多发于儿童和青少年。有关其治疗的数据有限,导致治疗的不确定性:我们介绍了两例肾尤文肉瘤儿科病例。两例病例都强调了准确诊断、多模式治疗和长期随访对取得良好疗效的重要意义。肾尤文肉瘤的准确诊断对于有效治疗至关重要。在我们的病例中,包括新辅助化疗、手术切除和淋巴结取样分期以及继续化疗在内的多模式治疗取得了良好的效果。长期随访对于监测疾病进展和确保最佳治疗效果至关重要:有关这些肾肿瘤的数据有限,尤其是在儿童群体中,而且大多数研究缺乏长期随访,由于数据有限,治疗方法也不确定。这些数据将为较新的多模式方法提供补充,并为未来的荟萃分析奠定基础,有助于为即将召开的国际会议制定指导方针。有必要继续开展研究工作,以优化策略,改善肾性尤文肉瘤儿科患者的预后。
{"title":"Pediatric Ewing Sarcoma of Kidney: A Case Series and Review of Literature.","authors":"Areej Salim, Sajid Ali, Tariq Latif","doi":"10.37029/jcas.v10i1.563","DOIUrl":"10.37029/jcas.v10i1.563","url":null,"abstract":"<p><strong>Introduction: </strong>Renal Ewing sarcoma is an aggressive and rare malignancy affecting children and adolescents. Limited data on its management contribute to uncertainties in treatment.</p><p><strong>Case description: </strong>We present two pediatric cases of renal Ewing sarcoma. Both cases emphasize the significance of accurate diagnosis, multimodal treatment, and long-term follow-up in achieving favorable outcomes. Accurate diagnosis of renal Ewing sarcoma is crucial for effective management. Multimodal treatment involving neoadjuvant chemotherapy, surgical resection and staging with lymph node sampling, and chemotherapy continuation has shown promising results in our cases. Long-term follow-up is essential for monitoring disease progression and ensuring optimal outcomes.</p><p><strong>Practical implications: </strong>There is limited data published about these renal tumors, especially in the pediatric population, and most studies lack long-term follow-up, with uncertain management due to limited data. This data will add to the newer, multimodal approach and form the basis for future meta-analysis to help formulate guidelines for upcoming international meetings. Continued research efforts are necessary to optimize strategies and improve the prognosis for pediatric patients with renal Ewing sarcoma.</p>","PeriodicalId":73631,"journal":{"name":"Journal of cancer & allied specialties","volume":"10 1","pages":"563"},"PeriodicalIF":0.0,"publicationDate":"2024-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10793718/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139520079","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Emergency Angioembolization for Life-Threatening Hemorrhage in Wilms Tumor. 紧急血管栓塞术治疗威尔姆斯肿瘤危及生命的出血。
Pub Date : 2024-01-22 eCollection Date: 2024-01-01 DOI: 10.37029/jcas.v10i1.603
Areej Salim, Sajid Ali, Muhammad Ali Sheikh, Tariq Latif, Islah Ud Din

Introduction: Renal artery embolization has been used in a palliative fashion for symptomatic relief of hematuria or flank pain in unresectable renal cell carcinoma in adults. There is limited data on the use of embolization for actively bleeding and unresectable tumors in the oncological pediatric population.

Case description: A previously healthy 5-year-old boy with no significant past medical or surgical history presented to the clinic with gradually worsening abdominal distension associated with occasional abdominal pain, gross hematuria, and lethargy for four months. Diagnostic investigations showed an 18-cm left-sided metastatic (pulmonary) renal tumor (Wilms), which was deemed unresectable on imaging. Treatment was planned according to the SIOP-RTSG protocol. However, he became hemodynamically and vitally unstable with acute, sudden distension of the abdomen on the left side after the first cycle of chemotherapy. Imaging showed active bleeding from an inferior branch of the left renal artery. Selective angioembolization was done, and chemotherapy was reinitiated with a patent left main renal artery. Following the fourth cycle of chemotherapy, he developed hemodynamic instability and abdominal pain; imaging revealed the resolution of pulmonary nodules and bleeding from the left renal artery (main); this was again embolized, and the patient was stabilized. The patient was operated on after optimization, and a complete resection of the mass was done with negative margins. On six months follow-up, he is well.

Practical implications: To the best of our knowledge, this is the first case where angioembolization has been done in conjunction with neoadjuvant chemotherapy to downsize a Wilms tumor to achieve favorable outcomes. Continued research efforts are necessary to optimize strategies and improve the prognosis for pediatric patients, and this case is one of the prime examples.

导言:肾动脉栓塞术已被用于缓解成人不可切除肾细胞癌患者的血尿或侧腹疼痛症状。在儿科肿瘤患者中,使用栓塞治疗活动性出血和不可切除肿瘤的数据有限:一名既往无明显内科或外科病史的 5 岁健康男孩因腹胀逐渐加重并伴有偶发性腹痛、毛细血尿和嗜睡 4 个月而就诊。诊断检查显示他患有 18 厘米的左侧转移性(肺)肾肿瘤(Wilms),影像学检查认为无法切除。根据 SIOP-RTSG 方案计划进行治疗。然而,第一个化疗周期结束后,他的左侧腹部突然出现急性腹胀,血流动力学和生命体征变得不稳定。影像学检查显示,左肾动脉下支有活动性出血。患者接受了选择性血管栓塞术,并在左肾主动脉通畅的情况下重新开始化疗。第四个化疗周期后,他出现了血流动力学不稳定和腹痛;造影显示肺结节消退,左肾动脉(主干)出血;再次进行了栓塞,患者病情稳定。经过优化后对患者进行了手术,在阴性边缘下完全切除了肿块。随访 6 个月后,患者情况良好:据我们所知,这是首例血管栓塞术与新辅助化疗相结合缩小 Wilms 肿瘤并取得良好疗效的病例。有必要继续开展研究工作,以优化策略并改善儿童患者的预后,本病例就是最好的例子之一。
{"title":"Emergency Angioembolization for Life-Threatening Hemorrhage in Wilms Tumor.","authors":"Areej Salim, Sajid Ali, Muhammad Ali Sheikh, Tariq Latif, Islah Ud Din","doi":"10.37029/jcas.v10i1.603","DOIUrl":"10.37029/jcas.v10i1.603","url":null,"abstract":"<p><strong>Introduction: </strong>Renal artery embolization has been used in a palliative fashion for symptomatic relief of hematuria or flank pain in unresectable renal cell carcinoma in adults. There is limited data on the use of embolization for actively bleeding and unresectable tumors in the oncological pediatric population.</p><p><strong>Case description: </strong>A previously healthy 5-year-old boy with no significant past medical or surgical history presented to the clinic with gradually worsening abdominal distension associated with occasional abdominal pain, gross hematuria, and lethargy for four months. Diagnostic investigations showed an 18-cm left-sided metastatic (pulmonary) renal tumor (Wilms), which was deemed unresectable on imaging. Treatment was planned according to the SIOP-RTSG protocol. However, he became hemodynamically and vitally unstable with acute, sudden distension of the abdomen on the left side after the first cycle of chemotherapy. Imaging showed active bleeding from an inferior branch of the left renal artery. Selective angioembolization was done, and chemotherapy was reinitiated with a patent left main renal artery. Following the fourth cycle of chemotherapy, he developed hemodynamic instability and abdominal pain; imaging revealed the resolution of pulmonary nodules and bleeding from the left renal artery (main); this was again embolized, and the patient was stabilized. The patient was operated on after optimization, and a complete resection of the mass was done with negative margins. On six months follow-up, he is well.</p><p><strong>Practical implications: </strong>To the best of our knowledge, this is the first case where angioembolization has been done in conjunction with neoadjuvant chemotherapy to downsize a Wilms tumor to achieve favorable outcomes. Continued research efforts are necessary to optimize strategies and improve the prognosis for pediatric patients, and this case is one of the prime examples.</p>","PeriodicalId":73631,"journal":{"name":"Journal of cancer & allied specialties","volume":"10 1","pages":"603"},"PeriodicalIF":0.0,"publicationDate":"2024-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10793714/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139522419","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of SSO-ASTRO Margin Guidelines on Re-excision Rate in Breast-conserving Surgery: A Single-center Experience. SSO-ASTRO边缘指南对保乳房手术中再次切除率的影响:单中心经验
Pub Date : 2024-01-22 eCollection Date: 2024-01-01 DOI: 10.37029/jcas.v10i1.559
Namra Urooj, Muhammad Abubakar, Kashif Asghar, Muhammad Hassan, Awais Amjad Malik, Bushra Rehman, Bakra Sajjad, Nifasat Farooqi, Zulqarnain Chaudhry, Asad Parvaiz, Amina Khan

Introduction: Breast-conserving surgery (BCS) has been historically linked with a high rate of re-excision. To address this issue, the Society of Surgical Oncology (SSO) and the American Society for Radiation Oncology (ASTRO) developed consensus guidelines in 2014 to standardize practices and improve clinical outcomes for BCS patients. In our tertiary cancer care hospital, we assessed the impact of these guidelines on the re-excision rate following BCS.

Materials and methods: We conducted a retrospective study on breast cancer patients who underwent BCS at the Shaukat Khanum Memorial Cancer Hospital and Research Centre in Lahore, Pakistan. The study compared the re-excision rate before the implementation of the SSO-ASTRO consensus guidelines (November 2015-July 2017) and after the implementation (January 2018-August 2019). Margins were considered positive if "ink on tumor" was present and negative if "no ink on tumor" was present. Fisher's exact test or Chi-square test was used to compare the re-excision rates between the pre- and post-guideline periods.

Results: A total of 919 patients were identified, with 533 from the pre-guideline period and 386 from the post-guideline period. Of the 919 patients, 31 with ductal carcinoma in situ (DCIS) were excluded from the re-excision analysis because the guidelines were not implemented on the DCIS. Furthermore, the overall rate of re-excision in our data was 4.3%. The re-excision rate decreased from 71.1% to 28.9% (P ≤ 0.05) following the adoption of the guidelines. We observed a statistically significant decrease in the re-excision rate after implementing the SSO-ASTRO guidelines.

Conclusion: Implementation of the SSO-ASTRO margin guidelines led to a notable decrease in the overall re-excision rate in our data set. These findings suggest that continued adherence to the guidelines may lead to a further reduction in the re-excision rate in the future.

简介保乳手术(BCS)历来与高重切率有关。为解决这一问题,肿瘤外科学会(SSO)和美国放射肿瘤学会(ASTRO)于 2014 年制定了共识指南,以规范操作并改善 BCS 患者的临床疗效。在我们的三级癌症治疗医院,我们评估了这些指南对 BCS 后再次切除率的影响:我们对在巴基斯坦拉合尔肖卡特-卡努姆纪念癌症医院和研究中心接受 BCS 的乳腺癌患者进行了一项回顾性研究。研究比较了SSO-ASTRO共识指南实施前(2015年11月-2017年7月)和实施后(2018年1月-2019年8月)的再切除率。如果 "肿瘤上有墨迹",则边缘被视为阳性;如果 "肿瘤上没有墨迹",则边缘被视为阴性。采用费雪精确检验或卡方检验比较指南实施前后的再切除率:结果:共发现 919 例患者,其中 533 例来自指南发布前,386 例来自指南发布后。在这 919 名患者中,有 31 名患有导管原位癌(DCIS)的患者被排除在再次切除分析之外,因为指南并未针对 DCIS 实施。此外,在我们的数据中,再次切除的总体比例为 4.3%。采用该指南后,再次切除率从 71.1% 降至 28.9%(P ≤ 0.05)。我们观察到,在实施 SSO-ASTRO 指南后,再次切除率在统计学上有了明显下降:结论:在我们的数据集中,SSO-ASTRO 边界指南的实施显著降低了总体再切除率。这些研究结果表明,今后继续遵循该指南可能会进一步降低再切除率。
{"title":"Impact of SSO-ASTRO Margin Guidelines on Re-excision Rate in Breast-conserving Surgery: A Single-center Experience.","authors":"Namra Urooj, Muhammad Abubakar, Kashif Asghar, Muhammad Hassan, Awais Amjad Malik, Bushra Rehman, Bakra Sajjad, Nifasat Farooqi, Zulqarnain Chaudhry, Asad Parvaiz, Amina Khan","doi":"10.37029/jcas.v10i1.559","DOIUrl":"10.37029/jcas.v10i1.559","url":null,"abstract":"<p><strong>Introduction: </strong>Breast-conserving surgery (BCS) has been historically linked with a high rate of re-excision. To address this issue, the Society of Surgical Oncology (SSO) and the American Society for Radiation Oncology (ASTRO) developed consensus guidelines in 2014 to standardize practices and improve clinical outcomes for BCS patients. In our tertiary cancer care hospital, we assessed the impact of these guidelines on the re-excision rate following BCS.</p><p><strong>Materials and methods: </strong>We conducted a retrospective study on breast cancer patients who underwent BCS at the Shaukat Khanum Memorial Cancer Hospital and Research Centre in Lahore, Pakistan. The study compared the re-excision rate before the implementation of the SSO-ASTRO consensus guidelines (November 2015-July 2017) and after the implementation (January 2018-August 2019). Margins were considered positive if \"ink on tumor\" was present and negative if \"no ink on tumor\" was present. Fisher's exact test or Chi-square test was used to compare the re-excision rates between the pre- and post-guideline periods.</p><p><strong>Results: </strong>A total of 919 patients were identified, with 533 from the pre-guideline period and 386 from the post-guideline period. Of the 919 patients, 31 with ductal carcinoma <i>in situ</i> (DCIS) were excluded from the re-excision analysis because the guidelines were not implemented on the DCIS. Furthermore, the overall rate of re-excision in our data was 4.3%. The re-excision rate decreased from 71.1% to 28.9% (<i>P</i> ≤ 0.05) following the adoption of the guidelines. We observed a statistically significant decrease in the re-excision rate after implementing the SSO-ASTRO guidelines.</p><p><strong>Conclusion: </strong>Implementation of the SSO-ASTRO margin guidelines led to a notable decrease in the overall re-excision rate in our data set. These findings suggest that continued adherence to the guidelines may lead to a further reduction in the re-excision rate in the future.</p>","PeriodicalId":73631,"journal":{"name":"Journal of cancer & allied specialties","volume":"10 1","pages":"559"},"PeriodicalIF":0.0,"publicationDate":"2024-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10793721/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139520056","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Systemic Diseases and Gastrointestinal Cancer Risk. 系统性疾病和胃肠道癌症风险。
Pub Date : 2023-01-01 DOI: 10.37029/jcas.v9i2.473
Naila Malkani, Muhammad Usman Rashid

Importance: Gastrointestinal (GI) cancers are the second leading cause of cancer-related deaths worldwide.

Observations: The global challenges GI cancers pose are high, especially in middle- and low-income countries. Patients with these cancers present with symptoms of poor appetite, weight loss, heartburn, abdominal pain, fatigue and anaemia. Several risk factors contribute to GI cancers, including age, gender, obesity, pathogenic infections, smoking cigarettes, alcohol consumption and dietary habits. Most of these cancers are sporadic. However, some patients are at high risk due to a family history of GI cancers. Systemic diseases affect multiple organs, and their chronic occurrence elicits inflammatory responses at various sites. These diseases also contribute to GI cancers.

Conclusion and relevance: In this review, we discuss that untreated systemic diseases, including diabetes, hepatitis, acquired immune deficiency syndrome, ulcers and hypertension, can potentially lead to GI cancers if they remain untreated for a longer period. Systemic diseases initiate oxidative stress, inflammatory pathways and genetic manipulations, which altogether confer risks to GI cancers. Here, we describe the association between systemic diseases and their underlying mechanisms leading to GI cancers.

重要性:胃肠道(GI)癌症是全球癌症相关死亡的第二大原因。观察结果:胃肠道癌症带来的全球挑战很高,特别是在中低收入国家。这些癌症的患者表现为食欲不振、体重减轻、胃灼热、腹痛、疲劳和贫血。有几个风险因素会导致胃肠道癌症,包括年龄、性别、肥胖、致病性感染、吸烟、饮酒和饮食习惯。这些癌症大多是散发性的。然而,由于有胃肠道癌症的家族史,一些患者的风险很高。全身性疾病影响多个器官,其慢性发生可引起不同部位的炎症反应。这些疾病也会导致胃肠道癌症。结论和相关性:在这篇综述中,我们讨论了未经治疗的全身性疾病,包括糖尿病、肝炎、获得性免疫缺陷综合征、溃疡和高血压,如果长期未经治疗,可能会导致胃肠道癌症。全身性疾病引发氧化应激、炎症途径和基因操纵,这些因素共同导致消化道癌症的风险。在这里,我们描述了全身性疾病及其导致胃肠道癌症的潜在机制之间的关联。
{"title":"Systemic Diseases and Gastrointestinal Cancer Risk.","authors":"Naila Malkani,&nbsp;Muhammad Usman Rashid","doi":"10.37029/jcas.v9i2.473","DOIUrl":"https://doi.org/10.37029/jcas.v9i2.473","url":null,"abstract":"<p><strong>Importance: </strong>Gastrointestinal (GI) cancers are the second leading cause of cancer-related deaths worldwide.</p><p><strong>Observations: </strong>The global challenges GI cancers pose are high, especially in middle- and low-income countries. Patients with these cancers present with symptoms of poor appetite, weight loss, heartburn, abdominal pain, fatigue and anaemia. Several risk factors contribute to GI cancers, including age, gender, obesity, pathogenic infections, smoking cigarettes, alcohol consumption and dietary habits. Most of these cancers are sporadic. However, some patients are at high risk due to a family history of GI cancers. Systemic diseases affect multiple organs, and their chronic occurrence elicits inflammatory responses at various sites. These diseases also contribute to GI cancers.</p><p><strong>Conclusion and relevance: </strong>In this review, we discuss that untreated systemic diseases, including diabetes, hepatitis, acquired immune deficiency syndrome, ulcers and hypertension, can potentially lead to GI cancers if they remain untreated for a longer period. Systemic diseases initiate oxidative stress, inflammatory pathways and genetic manipulations, which altogether confer risks to GI cancers. Here, we describe the association between systemic diseases and their underlying mechanisms leading to GI cancers.</p>","PeriodicalId":73631,"journal":{"name":"Journal of cancer & allied specialties","volume":"9 2","pages":"473"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/20/88/JCAS-9-473.PMC10405983.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9988924","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of cancer & allied specialties
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1